157848-08-3 Usage
General Description
5,7-Dichloro-4-hydroxy-quinoline-2-carboxylic acid ethyl ester is a chemical compound that belongs to the class of quinoline derivatives. It is an ethyl ester derivative of 5,7-dichloro-4-hydroxyquinoline-2-carboxylic acid and is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. 5,7-DICHLORO-4-HYDROXY-QUINOLINE-2-CARBOXYLIC ACID ETHYL ESTER has been studied for its antimicrobial, antiviral, and anticancer properties, and has shown potential as a therapeutic agent in the treatment of infectious diseases and cancer. It is important to handle this chemical with proper care and follow safety protocols, as it may pose health hazards if not used and stored properly.
Check Digit Verification of cas no
The CAS Registry Mumber 157848-08-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,8,4 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 157848-08:
(8*1)+(7*5)+(6*7)+(5*8)+(4*4)+(3*8)+(2*0)+(1*8)=173
173 % 10 = 3
So 157848-08-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H9Cl2NO3/c1-2-18-12(17)9-5-10(16)11-7(14)3-6(13)4-8(11)15-9/h3-5H,2H2,1H3,(H,15,16)
157848-08-3Relevant articles and documents
Process for preparing 1,4-dihydro-4-oxoquinoline-2-carboxylates and 4-aminoquinoline compounds therefrom
-
Page/Page column 18-20, (2021/01/17)
A method for preparing an alkyl 5,7-dihalo-1,4-dihydro-4-oxoquinoline-2-carboxylate ester is described herein. The method comprises cyclizing a compound of Formula III with Eaton's reagent in heated continuous flow reactor to form a compound of Formula IV
Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
-
, (2008/06/13)
The present invention relates to heterocyclic benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein including rheumatoid arthr
